O Kellner - Concepedia

Author

O Kellner

University Medical Center Freiburg

Also Known As

O Kellner, O. Kellner, Olaf Kellner

Publications

546

Citations

H-Index

Concepts

All Affiliations

University Medical Center Freiburg Humboldt-Universität zu Berlin Martin Luther University Halle-Wittenberg University of Cologne Ludwig-Maximilians-Universität München

About

O Kellner is an author at University Medical Center Freiburg specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	401
2	Pharmacology	4	4	153
3	Cancer Therapeutics	4	4	153
4	Health Sciences	1	1	40
5	Antibiotics	1	1	248

O Kellner

Publications

506

Citations

H-Index

Page 1

	Year	Citations
Antimicrobial therapy of unexplained fever in neutropenic patients Hartmut Link, A. B�hme, Oliver A. Cornely, Annals of Hematology AntibioticsHealthcare-associated InfectionSepsisInfection ControlMedicine	2003	248
Diagnosis and treatment of documented infections in neutropenic patients Dieter Buchheidt, Angelika Böhme, Oliver A. Cornely, Annals of Hematology Documented InfectionsHealthcare-associated Infection	2003	105
295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial Axel Grothey, Kim Jordan, O Kellner, European Journal of Cancer Supplements First-line TherapyOncologyGastrointestinal OncologyMedicineColorectal Cancer	2003	63
Capecitabine/ irinotecan (CapIri) and capecitabine/oxaliplatin (CapOx) are active second-line protocols in patients with advanced colorectal cancer (ACRC) after failure of first-line combination therapy: Results of a randomized phase II study Axel Grothey, Kim Jordan, O Kellner, Journal of Clinical Oncology Line CapiriSurgeryPharmacotherapyAdvanced Colorectal CancerCapiri Vs Capox	2004	40
Phase II Trial of Capecitabine/Irinotecan and Capecitabine/Oxaliplatin in Advanced Gastrointestinal Cancers Karin Jordan, O Kellner, Thomas Kegel, Clinical Colorectal Cancer Phase Ii TrialGastrointestinal OncologyMedicinePharmacologyAdvanced Gastrointestinal Cancers	2004	36
Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide S. Nagel, O Kellner, Walburga Engel-Riedel, Clinical Lung Cancer Darbepoetin AlfaOncologyPharmacologyDose-dense ChemotherapyPharmacotherapy	2011	14

Page 1